SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-28
👔
Scribe Therapeutics, Inc.
@SCTX_InsiderForm 4 Filing: Lucas Svetlana Buys $45,000 of $SCTX
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Scribe Therapeutics, Inc.
Ticker: $SCTX
Transaction Value
$45,000
Price/Share: $15.00
transaction date
2026-07-23
Shares: 3,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lucas Svetlana, holds the title of Chief Business Officer at Scribe Therapeutics, Inc..
On 2026-07-23, the insider transacted 3,000 shares.The shares were transacted at a weighted average price of $15.00 per share, resulting in a total market-relevant value of $45,000.
Executive Summary Summary
Lucas Svetlana (Chief Business Officer) bought $45K of $SCTX
Post-Transaction Position: 3,000 shares
SEC Accession No: 0001781292-26-000007 (CIK: 1781292)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.